Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 10, 2010 - Issue 8
Submit an article Journal homepage
418
Views
16
CrossRef citations to date
0
Altmetric
Reviews

The therapeutic potential of TNF-α antagonists for skin psoriasis comorbidities

Gérald E Piérard
, MD PhD,
Claudine Piérard-Franchimont University Hospital Sart Tilman, Department of Dermatopathology, B-4000 Liège, Belgium [email protected]
, MD PhD,
Grégory Szepetiuk University Hospital Sart Tilman, Department of Dermatopathology, B-4000 Liège, Belgium [email protected]
,
Philippe Paquet University Hospital Sart Tilman, Department of Dermatopathology, B-4000 Liège, Belgium [email protected]
, MD PhD &
Pascale Quatresooz University Hospital Sart Tilman, Department of Dermatopathology, B-4000 Liège, Belgium [email protected]
, MD PhD
Pages 1197-1208 | Published online: 13 Jul 2010

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Yue Zhao & Wei Lai. (2014) Patient considerations and targeted therapies in the management of psoriasis in Chinese patients: role of ustekinumab. Patient Preference and Adherence 8, pages 865-872.
Read now
Rik J Lories & Kurt de Vlam. (2014) Tumour necrosis factor inhibitors in the treatment of psoriatic arthritis: a view on effectiveness, clinical practice and toxicity. Expert Opinion on Biological Therapy 14:12, pages 1825-1836.
Read now
Bobbak Mansouri, Mahir Patel & Alan Menter. (2013) Biological therapies for psoriasis. Expert Opinion on Biological Therapy 13:12, pages 1715-1730.
Read now
Rosita Saraceno, Mauro Bavetta, Arianna Zangrilli, Andrea Chiricozzi, Concetta Potenza, Sergio Chimenti & Maria Sole Chimenti. (2013) Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis. Expert Opinion on Biological Therapy 13:9, pages 1325-1334.
Read now
Claudine Piérard-Franchimont, Gérald E Piérard & Pascale Quatresooz. (2011) Focus on skin cancer association and progression under TNF antagonist therapy. Expert Opinion on Biological Therapy 11:9, pages 1215-1222.
Read now

Articles from other publishers (11)

N. N. Potekaev, O. V. Zhukova & S. I. Artemyeva. (2020) Psoriasis: a personalized approach to therapy. The preferred choice of systemic agents considering comorbid pathologies. Meditsinskiy sovet = Medical Council:12, pages 28-34.
Crossref
Lana Bassi Ferdinando, Paula Kaori Fukumoto, Sarah Sanches, Lincoln Helder Zambaldi Fabricio & Thelma L Skare. (2018) Metabolic syndrome and psoriasis: a study in 97 patients. Revista da Associação Médica Brasileira 64:4, pages 368-373.
Crossref
Steven R. Feldman, Haijun Tian, Isabelle Gilloteau, Patrick Mollon & Meng Shu. (2017) Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database. BMC Health Services Research 17:1.
Crossref
Philippe Paquet, Serge Jennes, Anne Françoise Rousseau, Florence Libon, Philippe Delvenne & Gérald E. Piérard. (2014) Effect of N-acetylcysteine combined with infliximab on toxic epidermal necrolysis. A proof-of-concept study. Burns 40:8, pages 1707-1712.
Crossref
Srujan MarepallyCedar HA BoakyeApurva R PatelChandraiah GoduguRavi DoddapaneniPinaki R Desai & Mandip Singh. (2014) Topical administration of dual siRNAs using fusogenic lipid nanoparticles for treating psoriatic-like plaques. Nanomedicine 9:14, pages 2157-2174.
Crossref
Pinaki R. Desai, Srujan Marepally, Apurva R. Patel, Chandrashekhar Voshavar, Arabinda Chaudhuri & Mandip Singh. (2013) Topical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo. Journal of Controlled Release 170:1, pages 51-63.
Crossref
Claudine Piérard-Franchimont & Gérald E. Piérard. (2012) Ustekinumab Biotherapy and Real-Time Psoriasis Capacitance Mapping: A Pilot Study. Journal of Biomedicine and Biotechnology 2012, pages 1-5.
Crossref
Trinh Hermanns-Lê, Enzo Berardesca, Gérald E. Piérard, Marianne Lesuisse & Claudine Piérard-Franchimont. (2012) Challenging Regional Psoriasis and Ustekinumab Biotherapy: Impact of the Patterns of Disease. Journal of Biomedicine and Biotechnology 2012, pages 1-6.
Crossref
Pascale Quatresooz, Trinh Hermanns-Lê, Gérald E. Piérard, Philippe Humbert, Philippe Delvenne & Claudine Piérard-Franchimont. (2012) Ustekinumab in Psoriasis Immunopathology with Emphasis on the Th17-IL23 Axis: A Primer. Journal of Biomedicine and Biotechnology 2012, pages 1-5.
Crossref
Fabio Caputo, Stefano Parro & Giorgio Zoli. (2011) Adalimumab for a co-existing clinical condition of Crohn's disease and acrodermatitis continua of Hallopeau. Journal of Crohn's and Colitis 5:6, pages 649.
Crossref
Margarita Carlos & Melanie Ortleb. (2018) Treatment with Tumor Necrosis Factor Antagonists and Their Possible Effects on Morbidity and Mortality in Psoriasis Patients. Psoriasis Forum 17a:1, pages 56-62.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.